Multivariate analysis revealed that GNAS mutations in IPMN cases were associated with dilated main pancreatic ducts (MPD, p = 0.016), while no statistically independent associations with clinical variables were observed for KRAS mutations. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.